Factor VII recombinante activado en pacientes no hemofílicos con hemorragia aguda grave en la Unidad de Terapia Intensiva

SUMMARY Background. Severe hemorrhage is a frequent complication with multiple etiologies and high morbi-mortality observed among critically ill patients. Recombinant Factor VIIa (rFVIIa) constitutes a new therapeutic alternative. Objective. Analyze the evolution in a non-hemophiliac patient group with severe hemorrhage treated with rFVIIa. Material and Methods. Ten non-hemophiliac patients with severe hemorrhage, five men and five women between...